Hospitals

LabCorp Prices $400,000,000 in 2.300% Senior Notes Due 2024 and $650,000,000 in 2.950% Senior Notes Due 2029

Monday, November 18, 2019 - 11:45pm

LabCorp (NYSE: LH) announced today that it has priced its offering of $1,050,000,000 in senior notes.

Key Points: 
  • LabCorp (NYSE: LH) announced today that it has priced its offering of $1,050,000,000 in senior notes.
  • The offering consists of two tranches: $400,000,000 aggregate principal amount of 2.300% Senior Notes due 2024 (the 2024 Notes) and $650,000,000 aggregate principal amount of 2.950% Senior Notes due 2029 (the 2029 Notes and, together with the 2024 Notes, the Notes).
  • The Notes will be senior unsecured obligations and will rank equally with LabCorps existing and future senior unsecured debt.
  • Concurrently with this offering, LabCorp is conducting a cash tender offer for up to $300,000,000 aggregate purchase price of its 4.625% Senior Notes due Nov. 15, 2020 (the Tender Offer).

HealthTrust Addresses Drug Shortages by Supporting Member Access to Essential Medicines

Monday, November 18, 2019 - 4:04pm

Our rigor creates supply confidence for HealthTrust members for these essential medicines, said Vincent Jackson, vice president of HealthTrusts Pharmacy Services Group.

Key Points: 
  • Our rigor creates supply confidence for HealthTrust members for these essential medicines, said Vincent Jackson, vice president of HealthTrusts Pharmacy Services Group.
  • HealthTrust is working with Fresenius Kabi and other manufacturers that demonstrate the capabilities necessary to meet the strict criteria for SIMS inclusion.
  • Our purpose is to put lifesaving medicines in the hands of caregivers, and we are pleased to work with HealthTrust to help address the challenges drug shortages create for hospitals, said Scott Meacham, president, pharmaceuticals and devices, Fresenius Kabi USA.
  • In return for scale, predictable purchasing volumes and sustainable pricing, drug makers commit to manufacturing redundancies, and firm pricesimportant factors that can help insulate members from drug shortages.

2019 TripleTree iAwards – Call for Applications

Monday, November 18, 2019 - 4:00pm

TripleTree Holdings, LLC, a healthcare merchant that has advised and invested in high-growth healthcare businesses, is pleased to announce a call for applications for the 2019 TripleTree iAwards .

Key Points: 
  • TripleTree Holdings, LLC, a healthcare merchant that has advised and invested in high-growth healthcare businesses, is pleased to announce a call for applications for the 2019 TripleTree iAwards .
  • With the launch of this years iAwards, TripleTree and TT Capital Partners (TTCP) are focused on recognizing earlier stage companies, where there is tremendous innovation occurring across the healthcare industry, said Michael Carroll, chief marketing officer at TripleTree.
  • Companies that provide and offer innovative healthcare technology and services solutions, with annual revenue of $5-25 million, are encouraged to apply for the 2019 TripleTree iAwards.
  • Online applications for the 2019 TripleTree iAwards will be available through December 12, 2019.

ARS Treatment Centers Continues to Expand in Virginia With New Office-Based Opioid Treatment Facility in Winchester

Monday, November 18, 2019 - 3:36pm

ARS Treatment Centers , a category leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Winchester, VA.

Key Points: 
  • ARS Treatment Centers , a category leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Winchester, VA.
  • The new facility is a part of the companys new network of local clinics that provide critical treatment resources to combat the opioid crisis and strengthen Virginia communities.
  • The Winchester facility is the companys 7th ARS location in Virginia.
  • ARS Treatment Centers is a subsidiary of Crossroad Treatment Centers.

US General Services Administration Grants Award of Professional Services Schedule to Thought Leadership & Innovation Foundation

Monday, November 18, 2019 - 3:00pm

The Thought Leadership & Innovation Foundation (TLI) , a global nonprofit leading transformative change on issues relating to healthcare, education, economic empowerment and the environment, today announces that it has received notification from the U.S. General Services Administration (GSA) that TLI was granted award of the Professional Services Schedule (PSS).

Key Points: 
  • The Thought Leadership & Innovation Foundation (TLI) , a global nonprofit leading transformative change on issues relating to healthcare, education, economic empowerment and the environment, today announces that it has received notification from the U.S. General Services Administration (GSA) that TLI was granted award of the Professional Services Schedule (PSS).
  • The PSS is a GSA Multiple Award Schedule (MAS) program that consolidated eight professional services schedules.
  • GSA Schedules are fast, easy and effective contracting vehicles for both customers and vendors and we are gratified with this designation.
  • TLI Foundation is a nonprofit foundation focused on driving innovative thinking and action on global issues relating to health, education and economic empowerment.

The Medical Alley Association and Accenture Collaborate to Lead the Healthcare Transformation Initiative

Monday, November 18, 2019 - 3:00pm

In a move that reflects Medical Alleys position as the global epicenter of health innovation and care, the Medical Alley Association announces its collaboration with Accenture to lead phase one of the Healthcare Transformation Initiative at Medical Alley (HTIMA), a campaign that will redefine the course of healthcare.

Key Points: 
  • In a move that reflects Medical Alleys position as the global epicenter of health innovation and care, the Medical Alley Association announces its collaboration with Accenture to lead phase one of the Healthcare Transformation Initiative at Medical Alley (HTIMA), a campaign that will redefine the course of healthcare.
  • We look forward to working with the Medical Alley Association to help them further define and lead the evolution of the healthcare industry.
  • HTIMA was founded in 2019 by the Medical Alley Association board of directors and exists to bring healthcares top leaders together for the good of healthcare consumers all over the world, starting in the global epicenter of health innovation and care: Medical Alley.
  • Founded in 1984, the Medical Alley Association supports and advances the global leadership of Medical Alleys healthcare industry and its connectivity around the world.

The Dr. M. Lee Pearce Foundation Announces Grant Recipients for 2019

Monday, November 18, 2019 - 2:26pm

The $100,000 grant will assist the organization to further its work and develop new approaches in the care of the aged.

Key Points: 
  • The $100,000 grant will assist the organization to further its work and develop new approaches in the care of the aged.
  • We are committed to supporting organizations such as Sherrill House which combines two of Dr. Pearces passions classical music and medicine, said Charles Douglas, chairman and president of The Dr. M. Lee Pearce Foundation, Inc.
  • The Dr. M. Lee Pearce Foundation, Inc. was established in 1984 by entrepreneur and business executive M. Lee Pearce.
  • The foundation is dedicated to the support of classical music and to improving medical care with an emphasis on aging.

Collective Medical Introduces Enhanced Clinical Data Capabilities to Support Better Patient Outcomes

Monday, November 18, 2019 - 2:13pm

Collective Medical today announced enhanced product functionality to supply care teams with previously difficult to source clinical data to drive better care outcomes.

Key Points: 
  • Collective Medical today announced enhanced product functionality to supply care teams with previously difficult to source clinical data to drive better care outcomes.
  • Seamless care transitions and real-time visibility into patient activity are critically important for care teams to ensure the best possible patient outcome.
  • We are increasingly focused on utilizing rich clinical data assets, like CCDs, for the benefit of the patient, says Chris Klomp, CEO of Collective Medical.
  • Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care.

DentaQuest Announces 2019 Health Equity Heroes

Monday, November 18, 2019 - 3:00pm

DentaQuest, the purpose-driven oral health company dedicated to improving the oral health of all, today announced the 2019 DentaQuest Health Equity Heroes, six individuals and a team, who are breaking down barriers and improving health for at-risk individuals in seven states.

Key Points: 
  • DentaQuest, the purpose-driven oral health company dedicated to improving the oral health of all, today announced the 2019 DentaQuest Health Equity Heroes, six individuals and a team, who are breaking down barriers and improving health for at-risk individuals in seven states.
  • Now in its fifth year, the DentaQuest Health Equity Hero awards program celebrates and promotes grassroots work that expands access to health care and prevents disease.
  • The 2019 DentaQuest Health Equity Heroes are:
    Head Start teams across Alabama are working to ensure Alabamas low-income children get a good start for school but they are also making sure the children and their families and caregivers get the health care, education and social services they need.
  • In addition to recognizing and promoting the contributions of the DentaQuest Health Equity Heroes, DentaQuest provides charitable contributions to nonprofit organizations committed to promoting health equity and identified by each of the heroes.

LabCorp Announces a Tender Offer for up to $300,000,000 Principal Amount of Its Outstanding 4.625% Senior Notes Due 2020

Monday, November 18, 2019 - 1:56pm

Tenders of Notes will be accepted only in principal amounts equal to $1,000 or integral multiples of $1,000 in excess thereof.

Key Points: 
  • Tenders of Notes will be accepted only in principal amounts equal to $1,000 or integral multiples of $1,000 in excess thereof.
  • Subject to the Tender Cap, all Notes validly tendered and not validly withdrawn on or before the Early Tender Deadline will be accepted before any Notes validly tendered after the Early Tender Deadline.
  • Furthermore, if the Offer is fully subscribed as of the Early Tender Deadline, holders who validly tender Notes following the Early Tender Deadline will not have any of their Notes accepted for payment.
  • The tender offer is being made solely by means of the Offer to Purchase that LabCorp is distributing to holders of Notes.